Company / Working Capital per Share
LENZ Therapeutics, Inc. Working Capital per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$10.18
FY2025
5-year range
$4.78 / $24.87
FY2021-FY2025
Trend
+7.5%
vs FY2024
Sector context
#47 of 210
Health Care
What the data says
LENZ Therapeutics, Inc.'s working capital per share of $10.18 is higher than 78% of companies in the Health Care sector (FY2025). Working Capital per Share has fluctuated over the past 6 years, ranging from $-4.79 in FY2020 to $24.87 in FY2023.
Based on SEC 10-K filings.
10.18 in FY2025 with a 3-year CAGR of +28.7%. Top quartile in the Health Care sector.
Declined from $24.87 to $10.18 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +28.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-93.1% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 7.5% year-over-year.
- Ranks #47 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2023.
- Lowest working capital per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.71 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.18 | +7.5% |
| FY2024 | $9.47 | -61.9% |
| FY2023 | $24.87 | +420.3% |
| FY2022 | $4.78 | -62.6% |
| FY2021 | $12.78 | +366.7% |
| FY2020 | -$4.79 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026